Mar 20, 2023 / 08:00PM GMT
Yvonne Briggs - LHA Investor Relations - VP
Good afternoon. This is Yvonne Briggs with LHA. Thank you all for joining us today for OPKO Health's R&D Day highlighting ModeX Therapeutics multi-specific technology platforms. Following management's prepared remarks, we will host a question-and-answer session. (Operator's Instructions) Please note, this event is being recorded, and a replay will be available on OPKO Health's website.
I'd like to remind you that any statements made during this call by management other than statements of historical fact, will be considered forward-looking and as such, will be subject to risks and uncertainties that could materially affect the company's expected results.
Those forward-looking statements include, without limitation, the various risks described in the company's SEC filings, including the annual report on Form 10-K for the year ended December 31, 2022 and its subsequently filed SEC reports.
The contents from the webcast contain time-sensitive information that is accurate only as of the date of the live broadcast today, March 20, 2023.
OPKO Health Inc R&D Day (Virtual) Transcript
Feb 08, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers